Saito Biotech: Announcement on preparation for asset impairment in the third quarter of 2024
Saito Biotech: Announcement on preparing for asset impairment
Saito Biotech: Special Report on Non-operating Capital Occupation and Other Related Capital Transactions for the Semi-Annual Year 2024
Saito Biotech: Progress announcement on providing guarantees for wholly-owned subsidiaries
Shandong Sito Bio-technology: Announcement regarding the subsidiary's compliance inspection for pharmaceutical GMP
Shandong Sito Bio-technology: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Shandong Sito Bio-technology: Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Shandong Sito Bio-technology: Legal opinion on the 2023 Annual Shareholders' Meeting of Shandong Sito Bio-Technology Co., Ltd. by Guohao Law Firm (Hangzhou).
Shandong Sito Bio-technology: Announcement on the Notice of the 2023 Annual Shareholders' Meeting (with additional provisional proposals)
Shandong Sito Bio-technology: Announcement regarding the addition of temporary proposals to the 2023 Annual Shareholders Meeting.
Shandong Sito Bio-technology: Notice on the subsidiary receiving a notice of approval for the marketing application of chemical raw materials
Shandong Sito Bio-technology: Announcement on the subsidiary receiving the European CEP certificate for chemical raw materials
Shandong Sito Bio-technology: Announcement on the Notice of Convening the 2023 Annual General Meeting of Shareholders
Shandong Sito Bio-technology: Rules of Procedure for the Special Meeting of Independent Directors (April 2024)
Shandong Sito Bio-technology: Announcement on preparing to accrue asset impairment
Shandong Sito Bio-technology: 2023 Internal Control Evaluation Report
Shandong Sito Bio-technology: Announcement on holding an online briefing on the 2023 annual results
Shandong Sito Bio-technology: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Shandong Sito Bio-technology: Accounting Services Selection and Employment System (April 2024)
Shandong Sito Bio-technology: Announcement on the use of some idle funds raised by the company and its wholly-owned subsidiaries to temporarily supplement working capital
No Data
No Data